Detalles de la búsqueda
1.
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
N Engl J Med;
386(12): 1143-1154, 2022 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320644
2.
Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients.
Oncologist;
29(4): e455-e466, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37995303
3.
Spatial and single-cell explorations uncover prognostic significance and immunological functions of mitochondrial calcium uniporter in breast cancer.
Cancer Cell Int;
24(1): 140, 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38632642
4.
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer.
Future Oncol;
20(8): 423-436, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37387213
5.
Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer model.
Exp Cell Res;
429(1): 113652, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37209991
6.
Neuropathic Pain Affects Quality of Life in Breast Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy.
Pain Manag Nurs;
25(3): 308-315, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38278750
7.
Association of radiation dose to cardiac substructures with major ischaemic events following breast cancer radiotherapy.
Eur Heart J;
44(45): 4796-4807, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37585426
8.
Evaluating clinical efficacy of hospital-based surveillance with mammography and ultrasonography for breast cancer.
J Formos Med Assoc;
123(1): 78-87, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37400295
9.
Analgesia-nociception index accurately predicts inadequate pectoralis muscle fascia block (PECS) in patients undergoing breast surgery: A prospective observational study.
J Formos Med Assoc;
2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448346
10.
Genomic Alterations of Tumors in HER2-Low Breast Cancers.
Int J Mol Sci;
25(2)2024 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279318
11.
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study.
Breast Cancer Res;
25(1): 152, 2023 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38098088
12.
Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 taiwan cancer registry index cases.
Breast Cancer Res Treat;
201(3): 547-560, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470893
13.
The association of trastuzumab with atrial fibrillation and heart failure in breast cancer patients in routine clinical practice: a population-based propensity score matching and competing risk model analysis.
Breast Cancer Res Treat;
198(1): 113-122, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36586037
14.
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial).
BMC Cancer;
23(1): 865, 2023 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37710198
15.
Role of mitochondrial alterations in human cancer progression and cancer immunity.
J Biomed Sci;
30(1): 61, 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37525297
16.
The role of LSM1 in breast cancer: Shaping metabolism and tumor-associated macrophage infiltration.
Pharmacol Res;
198: 107008, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37995895
17.
A YOLO-based AI system for classifying calcifications on spot magnification mammograms.
Biomed Eng Online;
22(1): 54, 2023 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37237394
18.
Characteristics of breast cancers detected by screening mammography in Taiwan: a single institute's experience.
BMC Womens Health;
23(1): 330, 2023 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37344800
19.
Integrated analysis of pivotal biomarker of LSM1, immune cell infiltration and therapeutic drugs in breast cancer.
J Cell Mol Med;
26(14): 4007-4020, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35692083
20.
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial.
Breast Cancer Res Treat;
192(3): 593-602, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35138529